Expression of human leukocyte antigen-G in ovarian malignant tumor tissues.
Shujie Liu, Dong JianChun, Wang Yun-shan
Abstract
Shujie Liu, Dong JianChun, Wang Yun-shan
Abstract
Objective To evaluate expression of human leukocyte antigen-G(HLA-G),an important immunosuppressive molecule,in ovarian malignant tumor tissues and to explore its clinical significance.Methods HLA-G expression in 36 benign ovarian tumor tissues and 45 primary ovarian malignant tumor tissues were analyzed using SP immunohistochemical method with the anti-HLA-G monoclonal antibody 4H84.Also,we used RT-PCR to determine expression of HLA-G mRNA in fresh ovarian malignant and benign ovarian tumor tissues.Results ①HLA-G expression was detected in 30/45(66.67%) primary ovarian malignant tumor tissues and 4/36(11.11%) benign ovarian tumor tissues by an immunohistochemical method,and it was obviously higher in ovarian malignant tissues than in benign ovarian tumor tissues(P0.01).② HLA-G expression was significantly different among ovarian serous cystadenocarcinoma,mucinous cystadenocarcinoma and endometrioid carcinoma(P0.05).However,it was not significantly associated with age,tumor stage,grade and lymph node metastasis.③HLA-G mRNA was revealed in ovarian malignant tumor tissues by RT-PCR analysis but was not detected in benign ovarian tumor tissues and ovarian tumor-like lesions.Conclusion HLA-G mRNA and HLA-G protein are ectopically expressed in ovarian malignant tumor tissues,which indicate that immunosuppression plays an important role in occurrence and development of ovarian cancer cells.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate expression of human leukocyte antigen-G(HLA-G),an important immunosuppressive molecule,in ovarian malignant tumor tissues and to explore its clinical significance.Methods HLA-G expression in 36 benign ovarian tumor tissues and 45 primary ovarian malignant tumor tissues were analyzed using SP immunohistochemical method with the anti-HLA-G monoclonal antibody 4H84.Also,we used RT-PCR to determine expression of HLA-G mRNA in fresh ovarian malignant and benign ovarian tumor tissues.Results ①HLA-G expression was detected in 30/45(66.67%) primary ovarian malignant tumor tissues and 4/36(11.11%) benign ovarian tumor tissues by an immunohistochemical method,and it was obviously higher in ovarian malignant tissues than in benign ovarian tumor tissues(P0.01).② HLA-G expression was significantly different among ovarian serous cystadenocarcinoma,mucinous cystadenocarcinoma and endometrioid carcinoma(P0.05).However,it was not significantly associated with age,tumor stage,grade and lymph node metastasis.③HLA-G mRNA was revealed in ovarian malignant tumor tissues by RT-PCR analysis but was not detected in benign ovarian tumor tissues and ovarian tumor-like lesions.Conclusion HLA-G mRNA and HLA-G protein are ectopically expressed in ovarian malignant tumor tissues,which indicate that immunosuppression plays an important role in occurrence and development of ovarian cancer cells.
Key concepts: Ovarian tumor, Immunohistochemistry, Ovarian cancer, Ovarian carcinoma, Pathology, Serous cystadenocarcinoma, Metastasis, Biology